Cargando…

IGF-1R: SUMO-ing its weight in chemoresistant colorectal cancer

Detalles Bibliográficos
Autor principal:	Goel, Ajay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729482/ https://www.ncbi.nlm.nih.gov/pubmed/29123265 http://dx.doi.org/10.1038/bjc.2017.377

Ejemplares similares

MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression
por: Chen, Wen-Ting, et al.
Publicado: (2017)

TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer
por: Izumi, Daisuke, et al.
Publicado: (2019)

Q-ing tumor glutaminase therapy
por: Stine, Zachary E., et al.
Publicado: (2015)

IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling
por: Oliva, Claudia R., et al.
Publicado: (2018)

Spy'ing on differentiation in neuroblastoma
por: Podkowa, Monika, et al.
Publicado: (2014)

Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer
por: Sipos, Ferenc, et al.
Publicado: (2017)

'Rac'-ing upstream to treat rheumatoid arthritis
por: Firestein, Gary S
Publicado: (2010)

“Yap”-ing about the Antifibrotic Benefits of Prostacyclin
por: Huang, Steven K.
Publicado: (2019)

Expression of P33(ING1b) Protein in Colorectal Cancer
por: Fallahnezhad, Somayeh, et al.
Publicado: (2016)

PEG-ing down (and preventing?) the cause of pegloticase failure
por: Abeles, Aryeh M
Publicado: (2014)

NOTCH-ing up Surface Tension in the Fibrotic Lung
por: Lasky, Joseph A., et al.
Publicado: (2022)

CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016)

LK or IGF1R: When selectivity hurts
por: Puzanov, Igor, et al.
Publicado: (2015)

SUMO1 modification of IGF-1R combining with SNAI2 inhibited osteogenic differentiation of PDLSCs stimulated by high glucose
por: Jiang, Rongrong, et al.
Publicado: (2021)

Cancer chemoresistance and BAK
por: Fox, Joanna L.
Publicado: (2015)

“PIK”ing Out New Epigenetic Markers in Lung Disease
por: Swarr, Daniel, et al.
Publicado: (2020)

Targeting IGF-1R: throwing out the baby with the bathwater?
por: Basu, B, et al.
Publicado: (2011)

Metformin and ICG-001 Act Synergistically to Abrogate Cancer Stem Cells-Mediated Chemoresistance in Colorectal Cancer by Promoting Apoptosis and Autophagy
por: Roy, Souvick, et al.
Publicado: (2022)

SUMO‐modified insulin‐like growth factor 1 receptor (IGF‐1R) increases cell cycle progression and cell proliferation
por: Lin, Yingbo, et al.
Publicado: (2017)

Autoantibodies against SUMO1-DHX35 in long-COVID
por: Thurner, Lorenz, et al.
Publicado: (2022)

The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer
por: Li, Yang, et al.
Publicado: (2015)

PRS-ing Forward to Identify Genetic Risk in Idiopathic Pulmonary Fibrosis
por: Blackwell, Timothy S., et al.
Publicado: (2023)

SUMO in the DNA damage response
por: Hendriks, Ivo A., et al.
Publicado: (2015)

Undoing SUMO aids polyQ AR
por: Lieberman, Andrew P., et al.
Publicado: (2015)

MAP(kinase)-ing a Link between Obesity and Inflammation in Severe Asthma
por: Tatler, Amanda L.
Publicado: (2019)

“KEAP”ing Alveolar Macrophage Mitochondria Content in Chronic Obstructive Pulmonary Disease
por: Cloonan, Suzanne M.
Publicado: (2023)

Archibald Inglis
Publicado: (1889)

Mallet-ing
Publicado: (1860)

Inge Borghuis
por: Kiers, Bart
Publicado: (2020)

Cardiomyocyte cell cycle: Meis-ing something?
por: Mahmoud, Ahmed I, et al.
Publicado: (2014)

CLOCK’ing differences in DNA methylation signatures to understand the molecular etiology of lung cancer
por: Neely, Aaron M., et al.
Publicado: (2023)

IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R
por: Qiao, Chenyang, et al.
Publicado: (2021)

SNP-ing out the differences: Investigating differences between Clostridium difficile lab strains
por: Smits, Wiep Klaas
Publicado: (2016)

ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer
por: Melekhova, Anna, et al.
Publicado: (2021)

Expanding SUMO and ubiquitin-mediated signaling through hybrid SUMO-ubiquitin chains and their receptors
por: Guzzo, Catherine M., et al.
Publicado: (2013)

Obesity: an heavyweight player in breast cancer’s chemoresistance
por: Vaysse, Charlotte, et al.
Publicado: (2019)

miR-24-3p promotes colon cancer progression by targeting ING1
por: Gao, Zhiying, et al.
Publicado: (2020)

Transcriptional Regulation of ING5 and its Suppressive Effects on Gastric Cancer
por: Zheng, Hua-chuan, et al.
Publicado: (2022)

WT1 β’ing catenin into shape: a new interaction driving epigenetic plasticity in acute myeloid leukemia?
por: Grey, William
Publicado: (2022)

InACTIVatINg cancer cachexia
por: Mathew, Sam J.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g7au5ca4s2v44tlai26sk57n47